BHI Co., Ltd. (KOSDAQ:083650)

Verve Therapeutics Revenue

BHI Co., Ltd. had revenue of 135.27B KRW in the quarter ending March 31, 2025, with 85.07% growth. This brings the company's revenue in the last twelve months to 466.92B, up 30.84% year-over-year. In the year 2024, BHI Co., Ltd. had annual revenue of 404.74B with 10.16% growth.

• Revenue (ttm): 466.92B
• Revenue Growth: +30.84%
• P/S Ratio: 2.83
• Revenue / Employee: 1.25B
• Employees: 375
• Market Cap: 1,319.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	404.74B	37.34B	10.16%
Dec 31, 2023	367.40B	37.20B	11.27%
Dec 31, 2022	330.20B	95.31B	40.58%
Dec 31, 2021	234.88B	-8.56B	-3.52%
Dec 31, 2020	243.44B	20.59B	9.24%